Suppr超能文献

苯扎贝特对大鼠实验性肾病综合征高脂血症的影响。

The effect of bezafibrate on hyperlipidaemia in experimental nephrotic syndrome in rats.

作者信息

Williams A J, Baker F E, Walls J

出版信息

J Pharm Pharmacol. 1985 Oct;37(10):741-3. doi: 10.1111/j.2042-7158.1985.tb04957.x.

Abstract

The effects of bezafibrate on hyperlipidaemia in experimental nephrotic syndrome in rats has been investigated. The treated group received bezafibrate 10 mg kg-1 p.o. daily. No significant differences in total serum cholesterol occurred, but a significant reduction in serum triglyceride (P less than 0.005) and elevation in HDL cholesterol (P less than 0.005) occurred. These findings may have implications for therapeutic intervention in severe hyperlipidaemia of the nephrotic syndrome in man.

摘要

已对苯扎贝特对大鼠实验性肾病综合征高脂血症的影响进行了研究。治疗组每日口服苯扎贝特10mg/kg。血清总胆固醇无显著差异,但血清甘油三酯显著降低(P<0.005),高密度脂蛋白胆固醇升高(P<0.005)。这些发现可能对人类肾病综合征严重高脂血症的治疗干预具有启示意义。

相似文献

2
Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.
J Clin Pharm Ther. 1994 Dec;19(6):387-9. doi: 10.1111/j.1365-2710.1994.tb00698.x.
4
Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome.
Nephron. 1990;56(4):399-404. doi: 10.1159/000186183.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验